Molbio Diagnostics Ltd.

NSE: MOLBIO | BSE: 544866

Molbio Diagnostics Live Share Price Today, Share Analysis and Chart

Name: Molbio Diagnostics Ltd.: Is Infosys Ltd. worth buying?
Item: Molbio Diagnostics Ltd.
Rating: 0.45775
Author: Trendlyne DVM scores

aboutMolbio Diagnostics was incorporated on October 20, 2000. The company develops innovative point-of-care diagnostics through its patented ‘Truenat’ PCR platform, enabling rapid testing for 30+ diseases across 100+ countries. It also offers radiology, d... Read More

Tests Performed

40.10(3.15%)

774.2K

NSE+BSE Volume

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

16.8 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

6Positive7Negative

46.2%Pass in checklist

045

100

Check P/E Buy Sell Zone

Not enough data available

Molbio Diagnostics Stock Price Analysis

Day Price Range 3.2% 1 Day return	1314.1 (LTP) 1,242.81,344 LowHigh
Week Price Range 6.0% 1 Week return	1314.1 (LTP) 1,232.61,345 LowHigh
Month Price Range -13.2% 1 Month return	1314.1 (LTP) 1,228.51,673.7 LowHigh
52 Week Price Range 62.8% 1 Year return	1314.1 (LTP) 926.41,686.8 LowHigh

View full Price History/Seasonality

Competitors/Peers

Quarterly

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Molbio Diagnostics quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Molbio Diagnostics Jun-2026 Quarterly Revenue is Rs 401 Cr which is growth of 314.0% YoY.
POSITIVE
Quarterly Net Profit Molbio Diagnostics Jun-2026 Quarterly Net Profit is Rs 57 Cr which is growth of 522.4% YoY.

Molbio Diagnostics Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Jun '25
TOTAL_SR_Q Total Rev. ⌄	400.8	441.5	96.8
SR_Q Operating Rev.	399.4	438.7	95.3
OI_Q Other Income	1.4	2.7	1.5
OEXPNS_Q Operating Exp.	307.7	331.7	105
OEXPNS_Q Operating Exp.	307.7	331.7	105
OP_Q Operating Profit	91.6	107	-9.6
OPMPCT_Q Operating Profit Margin %	22.94%	24.40%	-10.11%
DEP_Q Depr.	8.4	9.9	7.4
INT_Q Interest	8.7	9.3	1.9
PBT_Q Profit Before Tax	75.9	90.7	-17.5
TAX_Q Tax	19.3	25	-4.1
NP_Q Net Profit	56.6	65.7	-13.4
EPS_adj_Q EPS Adj. latest	4.9	5.7	-1.2
NP_TTM Net profit TTM	-	-	-
EPS_TTM Basic EPS TTM	-	-	-
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Molbio Diagnostics Technical Analysis

Molbio Diagnostics EMA & SMA

Bearish-2

2 bullish, 4 bearish

Bullish2

Bearish4

5 Day	1299.4
10 Day	1317.3
12 Day	1324.4

20 Day	1335.7
26 Day	1331.3
50 Day	1282.2

Molbio Diagnostics Delivery And Volume

Daily Avg. Delivery Volume %

02 Nov, 202618.4%

Week20.1%

Month18.7%

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Molbio Diagnostics Resistance and Support

1300.30

Pivot

First Resistance	1357.8
Second Resistance	1401.5
Third Resistance	1459

First Support	1256.6
Second Support	1199.1
Third Support	1155.4

Day RSI	48.7
Day MACD	-6.8
Day MFI	67
Day MACD Signal Line	14.4

Molbio Diagnostics Beta

1 Month	1.7
1 Year	-

3 Month	-
3 Year	-

Molbio Diagnostics Price Change Analysis

↓-13.2%

Over 1 Month

LowHigh

1228.51673.7

↑62.8%

Over 3 Months

LowHigh

926.41686.8

↑62.8%

Over 6 Months

LowHigh

926.41686.8

↑62.8%

Over 1 Year

LowHigh

926.41686.8

Molbio Diagnostics Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Exxora Trading Llp	Promoter	42,693,951	37.1 %
V-Sciences Investments Pte Ltd	Public	10,070,150	8.7 %
Business Excellence Trust Iii - India Business Exc	Dii	10,276,750	8.9 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Molbio Diagnostics Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
HDFC MUTUAL FUND	Bulk	Purchase	30 Sep 2026	1315	2,300,000	BSE
BUSINESS EXCELLENCE TRUST III	Bulk	Sell	30 Sep 2026	1315.01	2,328,996	BSE
BUSINESS EXCELLENCE TRUST III	Bulk	Sell	23 Sep 2026	1315	2,996,798	BSE
KOTAK MAHINDRA MUTUAL FUND	Bulk	Purchase	23 Sep 2026	1315	2,750,000	BSE
JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	Sell	16 Sep 2026	1288.60	591,823	NSE
JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	Purchase	16 Sep 2026	1288.14	590,709	NSE
MICROCURVES TRADING PRIVATE LIMITED	Bulk	Sell	11 Sep 2026	1545.88	753,493	NSE
HRTI PRIVATE LIMITED	Bulk	Sell	11 Sep 2026	1547.45	601,018	NSE
JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	Sell	11 Sep 2026	1566.94	1,228,332	NSE
QE SECURITIES LLP	Bulk	Sell	11 Sep 2026	1552.02	1,188,458	NSE

All deals

All insider trades

Molbio Diagnostics Corporate Actions

Molbio Diagnostics Board Meetings

Molbio Diagnostics past and upcoming board meetings.

#Ex-Date	Purpose	Notes
105 Sep 2026	Quarterly Results	-

All Corporate Actions

Molbio Diagnostics Research Reports

Molbio Diagnostics research reports with share price targets, and buy/hold/sell recommendations from top brokers.

# Date	Broker Name	Target	Price When Recommended	Type	Upside	Change Since Recommendation	Links
104 Oct 2026	Motilal Oswal	1800	1503.4	Buy	19.73%	-12.59%	pdf
209 Aug 2026	Deven Choksey	-	-	IPO Subscribe	-	-%	pdf

All Reports of Molbio

Molbio Diagnostics Corporate Filings

Molbio Diagnostics BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Date	Announcement Title	Details	Links
02 Nov 2026	Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026.	PDF
02 Nov 2026	Molbio Diagnostics Ltd - 544866 - Board Meeting Intimation for Approval Of The Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2026.	Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026	PDF
19 Oct 2026	Molbio Diagnostics Ltd - 544866 - Clarification On Spurt In Volume Of Shares Of The Company.	Clarification on Spurt in Volume of shares of the Company.	PDF
19 Oct 2026	Molbio Diagnostics Ltd - 544866 - Clarification sought from Molbio Diagnostics Ltd	The Exchange has sought clarification from Molbio Diagnostics Ltd on October 19, 2026, with reference to Movement in Volume. The reply is awaited.	PDF
16 Oct 2026	Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011	The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund	PDF

VIEW ALL

Molbio Diagnostics DocumentsAsk MarketMind AI

Molbio Diagnostics Earnings Call

Molbio Diagnostics earnings calls, including management commentary and AI-generated summaries.

Date	Title	Links
12 Sep 2026	Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript	Link
08 Sep 2026	Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome	Link

view all

Molbio Diagnostics Investor Presentations

Molbio Diagnostics investor presentations, including business updates, financial insights, and strategic initiatives.

Date	Report Title	Links
08 Sep 2026	Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Investor Presentation	Link

Molbio Diagnostics - Company Profile

Molbio Diagnostics Management Structure

Molbio Diagnostics management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF
Mr. Shiva Sriram	President(Business Development)	401.4	Mar 26
CHANDRASEKHAR NAIR	Executive Director,Chief Technology Officer,Promoter	259.8	Mar 26
SRIRAM NATARAJAN	Executive Director,Chief Executive Officer	244.2	Mar 26
Ms. Reeti Desai Hobson	Vice President(Global Health Programs,Partnerships)	170.8	Mar 26
Dr. Kuldeep Singh Sachdeva	President(Partnerships)	140.8	Mar 26
Mr. Indraneil Borkakoty	President(Corporate Strategy.,Acquisitions,Investor Relations)	80.3	Mar 26
Ms. Sarah Sarika Frias Oliveira Fernandes	General Manager,Head(Human Resources,Administration)	47.1	Mar 26
Dr. Abhay Raorane	General Manager(Manufacturing)	45.5	Mar 26
Dr. Praveen Kumar M.K.	Deputy General Manager(Quality Control)	39.5	Mar 26
Mr. Manan Bimal Khokhani	President(Finance & Accounts),Chief Financial Officer	38.7	Mar 26
Dr. Sivakumar Selvaraj	Deputy General Manager(Quality Assurance)	36.7	Mar 26
Mr. Goli Udaya Bhaskar	General Manager,Head(Operations)	33.4	Mar 26
Mr. Mahendra V. Salunke	Senior Manager(Purchase)	25.7	Mar 26
Darshan Raghunath Karekar	Company Secretary,Compliance Officer	17.4	Mar 26

Molbio Diagnostics Board of Directors

Molbio Diagnostics Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Sriram Natarajan	Executive Director & CEO	244.2	Mar 26
Sangeetha Sriram	Executive Director (Operation)	143.8	Mar 26
Darshan Raghunath Karekar	Company Sec. & Compli. Officer	17.4	Mar 26
Arun Kumar Jha	Independent Director	15	Mar 26
Dr Balram Bhargava	Independent Director	15	Mar 26
Nupur Garg	Independent Director	15	Mar 26
Chandrasekhar Bhaskaran Nair	ED / Chief Technology Officer / Promoter	-	Mar 26

Website: www.molbiodiagnostics.com

About the company - Business Profile

Molbio Diagnostics was incorporated on October 20, 2000. The company develops innovative point-of-care diagnostics through its patented ‘Truenat’ PCR platform, enabling rapid testing for 30+ diseases across 100+ countries. It also offers radiology, digital pathology, and breast health solutions while building a pipeline of new products

Molbio Diagnostics FAQ

Molbio Diagnostics today is trading in the green, up by 3.15% at ₹1,314.1.

Molbio Diagnostics is currently trading up 3.15% on an intraday basis. In the past week the stock rose 6.05%. Stock has been up 62.84% in the past quarter and rose 62.84% in the past year. You can view this in the share price history/seasonality section.

Molbio Diagnostics is listed on NSE with the ticker MOLBIO and on BSE as 544866. It's currently trading on NSE at a share price of ₹1,314.1 and on BSE with a share price of ₹1,310.

The market cap of Molbio Diagnostics is ₹15,143.69 Cr. as of Nov 02, 2026.

Molbio Diagnostics has never announced any dividend since the time of its listing on the BSE/NSE exchanges.

Molbio Diagnostics has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.

Molbio Diagnostics reported ₹411.48 Cr. in revenue, ₹58.75 Cr. in net profit, and ₹103.68 Cr. in EBITD as of Sep 05, 2026 for Q1 FY26-27.

There are no analyst predictions for stock price target for Molbio Diagnostics.

The PE ratio of Molbio Diagnostics is not available as of Nov 03, 2026.

The PB ratio of Molbio Diagnostics is 12.95 as of Nov 02, 2026.

You can view the latest analyst reports on the Molbio Diagnostics reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Molbio Diagnostics Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Molbio Diagnostics Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Molbio Diagnostics - Quarterly

Molbio Diagnostics quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Molbio Diagnostics Jun-2026 Quarterly Revenue is Rs 401 Cr which is growth of 314.0% YoY.

Quarterly Net Profit Molbio Diagnostics Jun-2026 Quarterly Net Profit is Rs 57 Cr which is growth of 522.4% YoY.

Molbio Diagnostics Technical Analysis

Molbio Diagnostics EMA & SMA

Molbio Diagnostics Delivery And Volume

Molbio Diagnostics Resistance and Support

Molbio Diagnostics Beta

Molbio Diagnostics Price Change Analysis

Molbio Diagnostics Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Molbio Diagnostics Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Molbio Diagnostics Corporate Actions

Molbio Diagnostics Board Meetings

Molbio Diagnostics past and upcoming board meetings.

Molbio Diagnostics Research Reports

Molbio Diagnostics research reports with share price targets, and buy/hold/sell recommendations from top brokers.

Molbio Diagnostics Corporate Filings

Molbio Diagnostics BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

Molbio Diagnostics DocumentsAsk MarketMind AI

Molbio Diagnostics Earnings Call

Molbio Diagnostics earnings calls, including management commentary and AI-generated summaries.

Molbio Diagnostics Investor Presentations

Molbio Diagnostics investor presentations, including business updates, financial insights, and strategic initiatives.

Molbio Diagnostics - Company Profile

Molbio Diagnostics Management Structure

Molbio Diagnostics management structure with salaries, total experience, and qualifications.

Molbio Diagnostics Board of Directors

Molbio Diagnostics Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Molbio Diagnostics FAQ

How is Molbio Diagnostics today?

Molbio Diagnostics today is trading in the green, up by 3.15% at ₹1,314.1.

How has Molbio Diagnostics performed historically?

Molbio Diagnostics is currently trading up 3.15% on an intraday basis. In the past week the stock rose 6.05%. Stock has been up 62.84% in the past quarter and rose 62.84% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Molbio Diagnostics on NSE and BSE exchanges?

Molbio Diagnostics is listed on NSE with the ticker MOLBIO and on BSE as 544866. It's currently trading on NSE at a share price of ₹1,314.1 and on BSE with a share price of ₹1,310.

What is the market cap of Molbio Diagnostics?

The market cap of Molbio Diagnostics is ₹15,143.69 Cr. as of Nov 02, 2026.

When did Molbio Diagnostics last pay a dividend, and what has its dividend history been?

Molbio Diagnostics has never announced any dividend since the time of its listing on the BSE/NSE exchanges.

Has Molbio Diagnostics issued any bonus shares or share splits recently?

Molbio Diagnostics has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.

What do the financial statements and annual reports of Molbio Diagnostics Indicate?

Molbio Diagnostics reported ₹411.48 Cr. in revenue, ₹58.75 Cr. in net profit, and ₹103.68 Cr. in EBITD as of Sep 05, 2026 for Q1 FY26-27.

What is the target share price of Molbio Diagnostics according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Molbio Diagnostics.

What is the PE Ratio of Molbio Diagnostics?

The PE ratio of Molbio Diagnostics is not available as of Nov 03, 2026.

What is the PB Ratio of Molbio Diagnostics?

The PB ratio of Molbio Diagnostics is 12.95 as of Nov 02, 2026.

Where can I check the latest Research Reports about Molbio Diagnostics?

You can view the latest analyst reports on the Molbio Diagnostics reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.

How can I be notified of real time alerts about Molbio Diagnostics stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.